You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Boehringer Ingelheim
Harvard Business School
Moodys
AstraZeneca

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

MIDODRINE HYDROCHLORIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Midodrine Hydrochloride, and what generic alternatives are available?

Midodrine Hydrochloride is a drug marketed by Alembic Pharms Ltd, Apotex, Aurobindo Pharma Ltd, Chartwell Rx, Impax Pharms, Mylan Pharms Inc, Par Pharm Inc, Rubicon, Unique Pharm Labs, Xiromed, and Zydus. and is included in eleven NDAs.

The generic ingredient in MIDODRINE HYDROCHLORIDE is midodrine hydrochloride. There are thirteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the midodrine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Midodrine Hydrochloride

A generic version of MIDODRINE HYDROCHLORIDE was approved as midodrine hydrochloride by MYLAN PHARMS INC on September 10th, 2003.

  Get Started for $10

Drug patent expirations by year for MIDODRINE HYDROCHLORIDE
Recent Clinical Trials for MIDODRINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Vanderbilt University Medical CenterN/A
Vanderbilt University Medical CenterEarly Phase 1
AJA University of Medical SciencesPhase 3

See all MIDODRINE HYDROCHLORIDE clinical trials

Pharmacology for MIDODRINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for MIDODRINE HYDROCHLORIDE

US Patents and Regulatory Information for MIDODRINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 213055-002 Sep 1, 2020 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Xiromed MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 207849-001 Oct 1, 2020 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Zydus MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 213055-003 Sep 1, 2020 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Xiromed MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 207849-002 Oct 1, 2020 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Alembic Pharms Ltd MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 214734-001 Jan 21, 2021 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Mylan Pharms Inc MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 076577-003 Sep 10, 2003 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Rubicon MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 212543-003 Aug 19, 2019 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Baxter
Boehringer Ingelheim
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.